This implant can restore sight for patients with macular degeneration
More than 5 million people around the world have an advanced form of age-related macular degeneration (AMD) called geographic atrophy, in which cells in the retinas die off. And until now, no treatment could restore their vision. The PRIMA system, which was approved in Europe in July and is awaiting FDA clearance in the US,…
Contenu original affiche; la traduction localisee n'est pas encore disponible.
Ce qui s'est passé
More than 5 million people around the world have an advanced form of age-related macular degeneration (AMD) called geographic atrophy, in which cells in the retinas die off. And until now, no treatment could restore their vision. The PRIMA system, which was approved in Europe in July and is awaiting FDA clearance in the US,…
Pourquoi c'est important
The development may change operating conditions or market expectations around AMD. Further confirmation and measurable outcomes matter.
Entités concernées
Voir les preuves
1 articles · 1 publication d'origine · 1 independantes
- MIT Technology ReviewSource primaire · Confirme · EN · 100%This implant can restore sight for patients with macular degeneration ↗
Affirmations
- This implant can restore sight for patients with macular degeneration Observé
Divergences
Aucune divergence importante détectée dans les preuves disponibles.
Chronologie
- Premier signalement
Mouvement de marché suivant l'événement
La réaction du marché n'est pas encore disponible pour cet actif et cette fenêtre.